Evidence map›Paper›PMID 31547810›Full record

ArticleBMC complementary and alternative medicine2019

Anti-inflammatory activities of astringent persimmons (Diospyros kaki Thunb.) stalks of various cultivar types based on the stages of maturity in the Gyeongnam province.

Jieun Choi, Mi Jeong Kim, Richard Komakech, Haiyoung Jung, Youngmin Kang

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Heliyon · 2023
    Article
  2. Evaluation of Marker Compounds and Biological Activity of In Vitro Regenerated and CommercialEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Ethnopharmacological Potential ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Review
  7. Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jieun ChoiKorean Convergence Medicine major, University of Science & Technology (UST), Daejeon, 34054, Republic of Korea.
Mi Jeong KimImmunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Yuseong-gu, Daejeon, 34141, Republic of Korea.
Richard KomakechKorean Convergence Medicine major, University of Science & Technology (UST), Daejeon, 34054, Republic of Korea.
Haiyoung JungImmunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Yuseong-gu, Daejeon, 34141, Republic of Korea. haiyoung@kribb.re.kr.
Youngmin KangKorean Convergence Medicine major, University of Science & Technology (UST), Daejeon, 34054, Republic of Korea. ymkang@kiom.re.kr.
Korea Institute of Oriental Medicine · KRKorea Research Institute of Bioscience and Biotechnology · KRMinistry of Health · UG

Funding

Ministry of Science, ICT and Future Planning KIOM G15050; K17690;K18720,KSN1911420
6 · The paper itself

Abstract

backgroundNatural products play a significant role in human health in relation to the prevention and treatment of inflammatory conditions. One of the plants with great medicinal potentials is Diospyros kaki which is mainly cultivated in Asian countries including Korea, Japan, and China. Astringent D. kaki is a wild species with an astringent taste until they are Ripened. kaki calyx is a traditional Korean medicine (TKM) made from the stalks of astringent D. kaki and is used in treating bed-wetting, vomiting, and hiccupping. The present study was designed to investigate the potential anti-inflammatory activities of astringent D. kaki stalks based on cultivar types and stages of maturity.

methodsThe anti-inflammatory effects of the stalk extracts of local astringent D. kaki cultivar species were evaluated on RAW 264.7 cells. Cell viability was measured using a Cell Counting Kit-8 (CCK8) method. The anti-inflammatory effects were determined by measuring the nitric oxide (NO) concentration of the supernatant. Cellular signaling pathways were determined by quantitative polymerase chain reactions of inducible nitric oxide synthase (iNOS). Protein expression of iNOS and phospho-p65 was determined using western blot, and the nuclear localization of p65 was determined using confocal imaging in RAW 264.7 cells.

resultsWe found that the stage 1 (8-9 month) samples all showed a high percentage of tannic acid content and Gojongsi (Hamyang) stalks had the highest content. The stage 1 samples also showed the highest inhibition of NO production. Decreases in the expression of iNOS and phosphorylated p65, and in the nuclear localization of p65, were dose-dependent. All the extracts were nontoxic under 100 μg/ml concentration.

conclusionThis study provides insight into the changes in tannic acid content in astringent D. kaki and their anti-inflammatory effects, in relation to their stage of maturity. These results are expected to be useful in the verification of the efficacy of oriental medicine and the timing of proper harvest for medical use.

Indexed as

AnimalsAnti-Inflammatory AgentsDiospyrosHumansMacrophagesMiceNitric OxideNitric Oxide Synthase Type IIPlant ExtractsPlant StemsRAW 264.7 CellsRepublic of KoreaAnti-Inflammatory AgentsNitric OxideNitric Oxide Synthase Type IIPlant ExtractsAnti-inflammatoryAstringent D. kakiCultivarsKorean traditional medicine

Identifiers

PMID31547810
PMCPMC6757412
OpenAlexW2975433809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.